James Investment Research’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,079
Closed -$81K 522
2021
Q1
$81K Sell
2,079
-1,166
-36% -$54.7K 0.01% 342
2020
Q4
$142K Buy
3,245
+2,753
+560% +$94K 0.01% 294
2020
Q3
$14K Sell
492
-4,273
-90% -$135K ﹤0.01% 409
2020
Q2
$173K Buy
+4,765
New +$134K 0.02% 253

Other funds holding ONEM

James Investment Research's ONEM Position: Q2 2021 in Review

James Investment Research sold out of 1Life Healthcare (ONEM) in Q2 2021, closing a stake of 2,079 shares — an estimated $81K sold.

James Investment Research first reported a position in ONEM in Q2 2020 and held it in 4 quarters. The position peaked at $173K in Q2 2020. 220 funds tracked by Wall St. Rank hold ONEM as of Q2 2021.

  • James Investment Research reported no remaining 1Life Healthcare position as of Q2 2021 after selling out during the quarter.
  • James Investment Research sold 2,079 1Life Healthcare shares in Q2 2021, an estimated $81K.
  • James Investment Research first reported a position in 1Life Healthcare in Q2 2020 and held it in 4 quarters.
  • James Investment Research's 1Life Healthcare position peaked at $173K in Q2 2020.
  • 220 funds tracked by Wall St. Rank held 1Life Healthcare as of Q2 2021.

Based on James Investment Research's 13F filing for Q2 2021, filed 26 Jul 2021.